A Phase 3, Multicenter, Double-Blind, Placebo-Controlled, Single-Treatment Efficacy and Safety Study of MYOBLOC (Part A) Followed by Open-Label, Multiple-Treatment with MYOBLOC (Part B) in the Treatment of Troublesome Sialorrhea in Adult Subjects

Principal Investigator: Brad Racette, MD